Cell Therapy in solid tumours

Adoptive T-Cell Therapy for Solid Tumors Chimeric antigen receptor (CAR) T-cell therapy is an innovative form of immunotherapy wherein autologous T cells are genetically modified to express chimeric receptors encoding an antigen-explicit single-chain variable piece and different costimulatory atoms. Chimeric antigen receptor T-cell therapy is an innovative form of immunotherapy wherein autologous T cells are genetically modified to express chimeric receptors encoding an antigen-specific single-chain variable fragment and various costimulatory molecules. Upon organization, these adjusted T cells traffic to, and perceive, malignant growth cells in a HLA-autonomous way.

  • Adoptive T-cell Therapy
  • Tumor cell Therapy
  • Solid Tumor Cell Therapy

Related Conference of Cell Therapy in solid tumours

November 19-20, 2026

44th World Cancer Conference

Dubai, UAE
November 23-24, 2026

8th International Conference on Women Oncology

Miami, USA
November 23-24, 2026

7th Cancer Diagnostics & Treatment Conference

Miami, USA
November 24-25, 2026

6th International Conference on Oncology and Cancer

Paris, France
December 03-04, 2026

10th Global Meeting on Oncology and Radiology

Madrid, Spain
December 08-09, 2026

27th World Congress on Cancer Summit

Paris, France
December 08-09, 2026

14th Euro Breast Cancer and Therapeutics

Paris, France
February 15-16, 2027

5th World Congress on Oral Cancer

Singapore City, Singapore
April 15-16, 2027

12th World Conference on Breast and Cervical Cancer

Amsterdam, Netherlands
April 26-27, 2027

26th World Congress on Cancer and Diagnostics

Barcelona, Spain
April 27-28, 2027

37th Experts Meet On Cancer Research & Therapy

Paris, France
May 05-06, 2027

7th World Congress on Breast Cancer

Berlin, Germany
May 05-06, 2027

23rd International Conference on Cancer Research

Berlin, Germany

Cell Therapy in solid tumours Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in